SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-258844
Filing Date
2022-10-06
Accepted
2022-10-06 16:05:35
Documents
12
Period of Report
2022-10-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d323065d8k.htm   iXBRL 8-K 22643
  Complete submission text file 0001193125-22-258844.txt   142627

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA syrs-20221003.xsd EX-101.SCH 2852
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20221003_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20221003_pre.xml EX-101.PRE 11259
6 EXTRACTED XBRL INSTANCE DOCUMENT d323065d8k_htm.xml XML 3360
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 221298223
SIC: 2834 Pharmaceutical Preparations